DB

Dada Bhauso Lonkar

Active Director Director DIN 11342437
DIN 11342437 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dada Bhauso Lonkar

Data last updated:

Dada Bhauso Lonkar is a Director at Serumcure Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11342437
Primary Designation Director
Industry Pharma
First Appointment 14 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Oct 20252025Active

Board colleagues of Dada Bhauso Lonkar

NameDINCompanyDesignation
Rambha Dada Lonkar11342438Serumcure Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Serumcure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dada Bhauso Lonkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dada Bhauso Lonkar

Dada Bhauso Lonkar currently holds 1 directorship: Serumcure Pharmaceuticals Private Limited (Director, since 14 Oct 2025).

Dada Bhauso Lonkar was first appointed on 14 Oct 2025 as Director at Serumcure Pharmaceuticals Private Limited.

The current boards of Dada Bhauso Lonkar's companies include Rambha Dada Lonkar (Serumcure Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available